AngioDynamics Financials - Benzinga

AngioDynamics Inc

ANGONASDAQ

Trade with Public

Trade with Public

$11.23

-2.96-20.86%

Últ. Act.: Oct 8, 7:59 PM

$11.49

-2.70-19.05%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

AngioDynamics Financials

AngioDynamics (ANGO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

AngioDynamics Stock Is Falling Thursday: What's Going On?

ANGO stock drops 21% as AngioDynamics reports Q1 results, names Eric Honroth as new CEO, and reaffirms FY27 guidance.

Vandana Singh

Earnings Scheduled For October 8, 2026

Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss at $0.15 per share on revenue of $266.42 million. • Helen Of Troy (NASDAQ:HELE) is projected to report quarterly

Benzinga Insights

PRO
AngioDynamics Affirms FY2027 Adj EPS Guidance of $(0.29)-$(0.24) vs $(0.27) Est; Affirms FY2027 Sales Guidance of $336.000M-$341.000M vs $337.400M Est

AngioDynamics (NASDAQ:ANGO) affirms FY2027 Adj EPS guidance from $(0.29)-$(0.24) to $(0.29)-$(0.24) vs $(0.27) analyst estimate. Affirms FY2027 sales outlook from $336.000 million-$341.000 million to $336.000

Benzinga Newsdesk

PRO
AngioDynamics Q1 Adj. EPS $(0.04) Beats $(0.11) Estimate, Sales $80.915M Beat $80.500M Estimate

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.11) by 63.64 percent. This is a 60 percent increase over losses of $(0.10) per share from the

Benzinga Newsdesk

Earnings Scheduled For July 14, 2026

Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarterly earnings at $3.25 per share on revenue of $862.92 million. • JPMorgan Chase (NYSE:JPM) is projected to report

Benzinga Insights

PRO
AngioDynamics Sees FY2027 Adj EPS $(0.29)-$(0.24) vs $(0.16) Est; Sees Sales $336.000M-$341.000M vs $329.600M Est

AngioDynamics (NASDAQ:ANGO) is looking for FY2027 Adj EPS of $(0.29)-$(0.24) vs $(0.16) analyst estimate. sees sales of $336.000 million-$341.000 million vs $329.600 million analyst estimate.

Benzinga Newsdesk